Purpose of the study was the identification of parameters predictive of efficacy of Levetiracetam (LEV) administered in a group of 75 patients affected by epileptic partial seizures and resistent/intolerant to Topiramate treatment. Only the dose <2000 mg and the treatment lasting more than 10 months resulted significantly correlated with a favorable response to LEV.
|Translated title of the contribution||Levetiracetam for the treatment of epileptic partial seizures in Topiramate resistant patients|
|Number of pages||3|
|Journal||Bollettino - Lega Italiana contro l'Epilessia|
|Publication status||Published - Jul 2003|
ASJC Scopus subject areas
- Clinical Neurology